An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples